ADRIPEG 50 INJECTION

Content Reviewed By:

Written By:

• ADRIPEG 50 INJECTION utilizes liposomes coated with polyethylene glycol (PEG) to precisely target tumors and facilitate the release of medication specifically within cancer cells. This targeted approach minimizes exposure to healthy tissues, reducing potential side effects.
• Once inside cancer cells, the doxorubicin released from ADRIPEG 50 INJECTION acts by inserting itself into the DNA strands. This intercalation process disrupts vital cellular functions such as transcription (copying DNA into RNA) and DNA replication (duplication of DNA).
• Doxorubicin further interferes with topoisomerase II enzymes, which play a critical role in DNA repair. By inhibiting these enzymes, ADRIPEG 50 INJECTION prevents cancer cells from repairing damaged DNA, making them more susceptible to cell death.
• These combined actions trigger apoptosis (programmed cell death), cell cycle arrest (stopping cell division), and significant DNA damage in cancer cells, ultimately leading to their destruction.
• Furthermore, doxorubicin generates reactive oxygen species (ROS), which increase oxidative stress within cancer cells. This heightened oxidative stress contributes to accelerated tumor cell death, enhancing the overall effectiveness of the treatment.
• The unique formulation of ADRIPEG 50 INJECTION prolongs its circulation time in the bloodstream. This extended circulation allows for a greater opportunity for the medication to reach cancerous tissues. This preferential delivery of the drug to cancerous tissues, rather than healthy ones, is a key advantage of this liposomal formulation.

• ADRIPEG 50 INJECTION will be administered to you by a healthcare professional via intravenous infusion. This means the medication is delivered directly into your vein through a drip. The duration of the infusion can vary, typically ranging from 30 minutes to over an hour, depending on factors such as the prescribed dosage and your specific medical condition. Your doctor will determine the appropriate dose and frequency of administration based on your individual needs, considering the nature of your illness, your overall health, and other relevant factors. It's crucial to understand that ADRIPEG 50 INJECTION is not intended for self-administration. The procedure requires the expertise and supervision of trained medical personnel to ensure proper administration and to monitor for any potential side effects. The healthcare provider will carefully observe you during and after the infusion to manage any adverse reactions promptly and effectively. Always follow your doctor's instructions precisely and report any concerns or unusual symptoms to the medical staff immediately.
• It is essential to adhere to the prescribed treatment schedule and attend all scheduled appointments for ADRIPEG 50 INJECTION infusions. Consistent adherence to the treatment plan is vital for achieving the best possible outcomes. If you have any questions or concerns about the infusion process, the medication itself, or potential side effects, don't hesitate to ask your doctor or nurse. They are there to provide you with the information and support you need throughout your treatment journey. Remember that open communication with your healthcare team is key to a successful treatment experience.